STOCK TITAN

Protara Therapeutics, Inc. (TARA) Free Cash Flow by Year

TARA

Protara Therapeutics, Inc. recorded an outflow of $56.5M in free cash flow in fiscal year 2025. This represents a decrease of 57.4% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Protara Therapeutics, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$56.5M
YoY -57.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TARA Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Free Cash Flow-$56.5M-57.4%-$35.9M+4.6%-$37.6M-41.5%-$26.6M+24.3%-$35.1M-44.5%-$24.3M-342.8%-$5.5M+76.5%-$23.4M-4.3%-$22.4M+6.6%-$24.0M-34.9%-$17.8M-76.9%-$10.0M-50.6%-$6.7M+19.7%-$8.3M

TARA Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash FlowN/AN/A-$17.0M-82.4%-$12.5M-47.5%-$12.3M-$14.8M-$9.3M-7.0%-$8.4M-27.9%N/AN/A-$8.7M-72.9%-$6.6M-21.5%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Protara Therapeutics, Inc. financials

Frequently Asked Questions

What was Protara Therapeutics, Inc.'s free cash flow in fiscal year 2025?

Protara Therapeutics, Inc. recorded an outflow of $56.5M in free cash flow in fiscal year 2025.

How fast is Protara Therapeutics, Inc.'s free cash flow growing?

Protara Therapeutics, Inc. (TARA) free cash flow fell by 57.4% year over year, from -$35.9M to -$56.5M in fiscal year 2025.

How has Protara Therapeutics, Inc.'s free cash flow changed over the years?

Across the 14 fiscal years this page covers, Protara Therapeutics, Inc. (TARA) free cash flow went from -$8.3M in fiscal year 2012 to -$56.5M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Protara Therapeutics, Inc. (TARA) reported on that line in every period on record.